4.7 Article

Randomized Pilot Trial of Eight Weeks of Bedaquiline (TMC207) Treatment for Multidrug-Resistant Tuberculosis: Long-Term Outcome, Tolerability, and Effect on Emergence of Drug Resistance

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Chemistry, Medicinal

Phospholipidosis as a Function of Basicity, Lipophilicity, and Volume of Distribution of Compounds

Umesh M. Hanumegowda et al.

CHEMICAL RESEARCH IN TOXICOLOGY (2010)

Article Medicine, General & Internal

The Diarylquinoline TMC207 for Multidrug-Resistant Tuberculosis

Andreas H. Diacon et al.

NEW ENGLAND JOURNAL OF MEDICINE (2009)

Article Multidisciplinary Sciences

Early Outcomes of MDR-TB Treatment in a High HIV-Prevalence Setting in Southern Africa

Kwonjune J. Seung et al.

PLOS ONE (2009)

Article Multidisciplinary Sciences

A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis

K Andries et al.

SCIENCE (2005)

Article Critical Care Medicine

Treatment and outcome analysis of 205 patients with multidrug-resistant tuberculosis

ED Chan et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2004)

Review Medicine, Research & Experimental

Drug-induced phospholipidosis: Are there functional consequences?

MJ Reasor et al.

EXPERIMENTAL BIOLOGY AND MEDICINE (2001)